Department of Orthopaedic Surgery

Research Centers and Labs

The Department of Orthopaedic Surgery has 13 active and separate laboratories or research units that serve bench research in areas ranging from sports medicine to cancer research.

The Center for Cellular and Molecular Engineering (Rocky Tuan, director), the Molecular Therapeutics Laboratory (Bing Wang, director), the Musculoskeletal Oncology Laboratory (Kurt Weiss, director), the Musculoskeletal Growth & Regeneration Lab (MaCalus Hogan, director), and the Arthritis and Arthroplasty Design Lab (Kenneth Urish, director) are located off the Oakland Campus at the Bridgeside Point 2 Research Facility.

The Biodynamics Laboratory (William Anderst, director) and the Neuromuscular Research Laboratory are located in the RiverTech Complex near the Sports Medicine Center.

The Sports Medicine Concussion Program Lab (Micky Collins, director) is located in the Sports Medicine Center.

The Orthopaedic Engineering Laboratory (Freddie Fu and Patrick Smolinski, co-directors) is a joint function with the Department of Mechanical Engineering and Materials Science and is located in the Swanson School of Engineering on campus. It houses the Double-Bundle Anterior Cruciate Ligament Reconstruction Study Group. The Orthopaedic Robotics Laboratory, a 1,500-square-foot research unit located in the Center for Bioengineering, focuses on the prevention of degenerative joint disease by improving diagnostic, repair and rehabilitation procedures for musculoskeletal injuries using state-of-the-art robotic technology. The lab serves as a multi-disciplinary core facility with collaboration promoted among investigators, (Volker Musahl and Richard E. Debski, co-directors and both faculty in orthopaedic surgery and bioengineering).

The Ferguson Laboratory for Orthopaedic and Spine Research (co-directed by Nam Vo and Gwendolyn Sowa) and the MechanoBiology Laboratory (James Wang, director) are located in the Bioscience Tower 1 on the hospital campus.

The Outcome Research unit (directed by Jay Irrgang), with a heavy emphasis on outcomes research, involves participation by each of our clinical divisions.